Feed NSISBC.XD
NS
Novonesis (Novozymes) B
NSISBC.XD · DXE
424.60 kr +1.77% (+7.40 kr)
1M -1.75%
Market Cap 116.0B kr
P/E Ratio 50.86x
Div. Yield -
ROE 2.77%
Bulios Fair Price
254.72 kr
40.0% downside
Preț actual
424.6 kr
Subevaluat Valoare justă Supraevaluat
Potrivit Bulios Fair Price, acțiunile NSISBC.XD sunt în prezent supraevaluate față de prețul lor de piață. Cum funcționează?
Valuation
33 /100
Expensive P/E 50.86x
P/B 1.39x
EV/EBITDA 15.77x
Growth
73 /100
Growing EPS growth 9.91%
Book val. growth 91.72%
Rev. growth 24.12%
Profitability
89 /100
Strong Gross margin 52.00%
FCF margin 17.78%
Net margin 7.98%
Quality
22 /100
Poor ROIC 2.56%
Asset turnover 0.25x
ROE 2.77%
Debt
94 /100
Low Debt/Equity 0.16x
Net debt/EBITDA 1.40x
Current ratio 1.73x
Stability
88 /100
Stable Beta 0.93x
Profitable years 4
Rev. volatility 29.90%
Întreabă StockBot despre NSISBC.XD
Online
Sector
Basic Materials
Industry
Chemicals - Specialty
CEO
-
Employees
10,582
Headquarters
Kongens Lyngby